Install the Sina Finance client to receive the most comprehensive market information the first time →[download link]
Most popular Chinese concept stocks closed lower on Wednesday.IQIYIIt fell more than 3%, and the intraday drop was close to 10%. Prior to this, the company announced a member price increase.
Qingke,SuntechRose more than 12%,RenrenRose by nearly 10%, bit numbers,China Global ShippingRose nearly 7%,36 KryptonRose nearly 5%,In the grid line、FirstNine citiescityRose more than 2%,NetEaseYoudao rose nearly 2%,Tucson FutureRose more than 1%.
Fun shopIt fell by more than 15%, Gaotu fell by more than 11%, 51Talk fell by nearly 11%, Ebon International fell by more than 8%, and Luckin’s fans fell by more than 7%.Phoenix New Media、Thunder、Dingdong ShoppingFell more than 6%,Kingsoft CloudFell nearly 6%,Jingdong、YunmiTechnology fell by more than 5%,Funny headlines、Huya、Bilibili、PinduoduoFell more than 4%,AliBaba,IQIYI,aurora、Cow、Fog coreTechnology fell more than 3%,HM>Auto House, Ctrip fell nearly 3%,Cheetah Mobile、Fighting fish、LejuFell more than 2%, Tencent’s ADR and Ctrip fell nearly 2%,Baidu, Huanju Group,FutuThe holding fell by more than 1%.
Among new energy vehicle stocks,Wei LaiAutomobiles fell more than 4%, and Xiaopeng Motors fell nearly 3%.idealCars fell 2%.
US stocks closed higher on Wednesday, with technology stocks leading the way. The Dow closed up 383.25 points, or 1.08%, to 35,927.43; the Nasdaq rose 327.94 points, or 2.15%, to 15,565.58 points; the S&P 500 index rose 75.76 points, or 1.63%, to 4,709.85 points.
List of leading Chinese stocks:
List of leading stocks:
(The screenshots are from Sina Finance APP Quotes-U.S. Stocks-Popular Stocks in China)Download Sina Finance APP
Hot info
IQiyi announces member price increase: the annual subscription will not change, and the monthly subscription will increase slightly
IQiyi announced that it will adjust the price of gold members from the 16th of this month, and the price of the annual card will remain unchanged. The increase is mainly for monthly and quarterly cards, with an increase of 9%-20%. Among them, the monthly average for consecutive years is about 18 yuan per month, which is still in the low price range. Regarding this price adjustment, iQiyi said, “The membership subscription price of the video platform has always been low. This phenomenon has affected the healthy development of the industry. In order to establish a more benign industrial ecology, excellent content producers will be rewarded. In the end, to provide members with more and better content, we decided to make adjustments to member prices. We will continue to work hard to make content, make products, and serve users.”
Canaan TechnologySigned an order for 30,000 machines with Genesis, and a contract for 150,000 machines to be executed
A few days ago, Canaan Technology (CAN.US) and the North American company Genesis Digital Assets Limited (hereinafter referred to as Genesis) signed the first phase of the 30,000 machine option contract, which is expected to be completed in the first quarter of 2022. According to the previously signed agreement, the two parties still have an option contract of 60,000 for the second phase and 90,000 for the third phase, totaling 150,000 machines to be executed.
The latest contract is part of the option order signed by the two parties in the third quarter. Public information shows that at the end of August this year, Canaan Technology and Genesis signed an order for a total of 20,000 units + 180,000 units of purchase options, which is the largest machine purchase agreement in the industry so far.
UxinQ2 financial report: transaction volume rose 37.5% year-on-year, customer net recommendation index hit a new high
Uxin Group (UXIN.US) released an unaudited financial report for the second quarter of fiscal year 2022. In the quarter, used car transaction volume increased by 37.5% year-on-year, and Uxin returned to a rapid growth track. At the same time, Uxin’s NPS Index (Customer Net Recommendation Index) also hit a new high of 56 points.
The financial report shows that as of September 30, 2021, Uxin used car trading volume was 3648, compared with 3,011 in the previous quarter, an increase of 21.2% from the previous quarter; an increase of 37.5% year-on-year; total revenue was RMB 346 million, compared with 278 million in the previous quarter Yuan, a month-on-month increase of 24.5%; a year-on-year increase of 352.7%, a gross profit margin of 4.2%, and a negative 22.4% in the same period last year; at the same time, the loss continued to narrow and the overall operation returned to a rapid growth track.
Dane TechnologyBecause the closing price is less than $1 for 30 consecutive trading days, receivedNasdaqDelisting warning
Dane Technology (TEDU.US) recently announced that it received a written notice from the Nasdaq listing qualification department on December 10, 2021, stating that the closing price of the company’s ADS for the past 30 consecutive trading days was lower than the For a share of US$1.00, the company no longer meets the minimum transaction price requirements of the Nasdaq Global Select Market as stipulated in Nasdaq’s Listing Rules 5450(a)(1).
According to the Nasdaq listing rules, the applicable grace period for restoring compliance is 180 calendar days, or until June 8, 2022. If the closing price of its ADS is $1.00 per share or higher for at least 10 consecutive trading days during the grace period, the company can make up for this lack.
Earlier, on December 1, 2021, Dane Technology stated that it would split each ADS representing 1 share of Class A common stock into 5 shares of Class A common stock for each ADS. If the U.S. Securities and Exchange Commission (SEC) agrees to its amendment, the move will take effect on December 23, 2021. Dane Technology believes that the stock split will help the company re-compliance with the minimum transaction price requirements, however, the company cannot guarantee that this goal will be achieved.
TJ-CD4B bispecific antibody TJ-CD4B is approved for Phase 1 clinical trial in China
IMAB.US announced that the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) of China has officially approved the bispecific antibody TJ-CD4B (also known as ABL111) for the treatment of solid tumors (including gastric cancer, esophagus and stomach). Borderline adenocarcinoma, esophageal adenocarcinoma and pancreatic duct adenocarcinoma) phase 1 clinical study.
TJBio has been approved in the United States in June this year to initiate a phase 1 clinical trial of TJ-CD4B for the treatment of advanced solid tumors (NCT04900818). The phase 1 clinical trial approved in China this time will be used as a dose extension for the US study Partially launched to speed up the global clinical development process of TJ-CD4B in an all-round way.
TJ-CD4B, as the first clinically innovative bispecific antibody targeting the tumor antigen claudin 18 splice body 2 (Claudin 18.2) and T cell costimulatory molecule 4-1BB, it specifically binds to these two targets at the same time It can increase lymphocyte tumor infiltration and enhance tumor immune response, and has the potential to treat gastric cancer, pancreatic cancer and a variety of malignant solid tumors.
Massive information and precise interpretation, all in Sina Finance APP
Editor in charge: Zhang Yujie SF107
.